Pink SheetThe US Food and Drug Administration beats the European Medicines Agency to approval of novel agents across the board, but the imbalance is even more stark in oncology, the largest therapy area, a Pin
Pink SheetA US Food and Drug Administration advisory committee generally supported a proposal that would eliminate the need for animal dosimetry data for some new positron emission tomography (PET) drugs, altho
Pink SheetZtalmy (ganaxolone), Marinus Pharmaceuticals ' treatment for epileptic seizures associated with a certain genetic disorder, and Curium 's diagnostic agent for prostate cancer, Pylclari (piflufolasta
Pink SheetMarinus Pharmaceuticals could learn this week whether the European Medicines Agency will recommend that its drug ganaxolone be authorized for marketing across the EU for treating epileptic seizures a